Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Maintenance of patient-reported health-related quality of life post neoadjuvant relugolix prior to the initiation of prostate radiation therapy.
Journal: Frontiers in oncology
Published: September 15, 2024
Safety and early efficacy of involved-field SBRT for nodal oligo-recurrent prostate cancer.
Journal: Frontiers in oncology
Published: May 17, 2024
Comparative analysis of plan quality and delivery efficiency: ZAP-X vs. CyberKnife for brain metastases treatment.
Journal: Frontiers in oncology
Published: November 05, 2023
Intensity modulated radiation therapy with stereotactic body radiation therapy boost for unfavorable prostate cancer: five-year outcomes.
Journal: Frontiers in oncology
Published: June 15, 2023
Dosimetric predictors of acute bowel toxicity after Stereotactic Body Radiotherapy (SBRT) in the definitive treatment of localized prostate cancer.
Journal: Acta oncologica (Stockholm, Sweden)
Published: February 24, 2023
Novel Paired Normal Prostate and Prostate Cancer Model Cell Systems Derived from African American Patients.
Journal: Cancer research communications
Published: May 19, 2022
High-Risk Non-Small Cell Lung Cancer Treated With Active Scanning Proton Beam Radiation Therapy and Immunotherapy.
Journal: Advances in radiation oncology
Published: April 12, 2022
Rationale for Utilization of Hydrogel Rectal Spacers in Dose Escalated SBRT for the Treatment of Unfavorable Risk Prostate Cancer.
Journal: Frontiers in oncology
Published: January 23, 2022
Patient-Reported Financial Burden Following Stereotactic Body Radiation Therapy for Localized Prostate Cancer.
Journal: Frontiers in oncology
Published: January 11, 2022
Volume of Disease as a Predictor for Clinical Outcomes in Patients With Melanoma Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint Therapy.
Journal: Frontiers in oncology
Published: October 13, 2021
Last Updated: 09/26/2026